Medical Devices Today

The Interventional Suite Of The Future

Article preview from Medtech Insight - October 1, 2011

The cardiac interventional suite has historically been a setting where high-tech, cutting-edge tools are welcomed. But with hospitals scrutinizing expenditures more closely than ever before, such tools must now prove themselves.AHospitals looking to build new interventional suites, or modernize old ones, are placinga premium on technologies that can improve safety, efficiency, and flexibility while streamlining workflow. A handful of companies are now offering products designed to meet these needs, and providers are starting to take notice.

Orthopedics M&A; Moving From Center To Extremities

Article preview from Start-Up - October 1, 2011

For the past few years, medical device VCs have slowly steered their capital away from spine start-ups and towards other opportunities in orthopedics, like extremities. Now, after years of near zero acquisition activity, strategic acquirers made not one but two significant acquisitions of extremities companies, creating a bit of a race to acquire a share of this small, but growing market.

Getinge/Maquet CV Emerging As Mid-Cap Strategic With Atrium Acquisition

Article preview from IN VIVO - October 1, 2011

At a time when the cardiovascular device industry is seeing less interest in M&A on the part of several large strategic players that formerly were major acquirers, a new mid-cap player appears to be emerging: Getinge's Maquet Cardiovascular division. The company recently announced its third major cardiovascular deal in the last five years with its $680 million acquisition of Hudson, NH-based Atrium Medical, which has a diversified cardiovascular products business.